EA201000883A1 - Производные индолинона и способ их получения - Google Patents

Производные индолинона и способ их получения

Info

Publication number
EA201000883A1
EA201000883A1 EA201000883A EA201000883A EA201000883A1 EA 201000883 A1 EA201000883 A1 EA 201000883A1 EA 201000883 A EA201000883 A EA 201000883A EA 201000883 A EA201000883 A EA 201000883A EA 201000883 A1 EA201000883 A1 EA 201000883A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
indolinona
production
hydrogen atom
group
Prior art date
Application number
EA201000883A
Other languages
English (en)
Other versions
EA016196B1 (ru
Inventor
Йёрн Мертен
Свенья Реннер
Карстен Райхель
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40718253&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201000883(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA201000883A1 publication Critical patent/EA201000883A1/ru
Publication of EA016196B1 publication Critical patent/EA016196B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

В заявке описаны особые производные индолинона, а именно соединения формулыв которой Rобозначает атом водорода или Cl-CH-CO-rpynny, a Rи Rкаждый обозначает атом водорода или Rи Rвместе представляют собой-группу, при условии, что, если Rобозначает атом водорода, то Rи Rвместе представляют собой-группу, а также способ их получения.
EA201000883A 2007-12-03 2008-12-02 Производные индолинона и способ их получения EA016196B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122123 2007-12-03
PCT/EP2008/066581 WO2009071524A2 (en) 2007-12-03 2008-12-02 Indolinone derivatives and process for their manufacture

Publications (2)

Publication Number Publication Date
EA201000883A1 true EA201000883A1 (ru) 2010-12-30
EA016196B1 EA016196B1 (ru) 2012-03-30

Family

ID=40718253

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000883A EA016196B1 (ru) 2007-12-03 2008-12-02 Производные индолинона и способ их получения

Country Status (36)

Country Link
US (1) US8067617B2 (ru)
EP (1) EP2229360B1 (ru)
JP (2) JP5933924B2 (ru)
KR (2) KR101676261B1 (ru)
CN (1) CN101883755B (ru)
AR (1) AR069531A1 (ru)
AU (1) AU2008333287B2 (ru)
BR (1) BRPI0819991B1 (ru)
CA (1) CA2705490C (ru)
CL (1) CL2008003599A1 (ru)
CO (1) CO6210751A2 (ru)
CY (1) CY1123333T1 (ru)
DK (1) DK2229360T3 (ru)
EA (1) EA016196B1 (ru)
EC (1) ECSP10010195A (ru)
ES (1) ES2818993T3 (ru)
HK (1) HK1145682A1 (ru)
HR (1) HRP20201480T1 (ru)
HU (1) HUE051550T2 (ru)
IL (1) IL205348A (ru)
LT (1) LT2229360T (ru)
MA (1) MA31989B1 (ru)
MX (1) MX2010005557A (ru)
MY (1) MY148574A (ru)
NZ (1) NZ585798A (ru)
PE (1) PE20091445A1 (ru)
PL (1) PL2229360T3 (ru)
PT (1) PT2229360T (ru)
RS (1) RS60818B1 (ru)
SI (1) SI2229360T1 (ru)
TN (1) TN2010000248A1 (ru)
TW (1) TWI432415B (ru)
UA (1) UA97872C2 (ru)
UY (1) UY31506A1 (ru)
WO (1) WO2009071524A2 (ru)
ZA (1) ZA201002723B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN103787949A (zh) * 2012-10-31 2014-05-14 韩冰 一类保护移植器官的化合物及其用途
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
US20140342772A1 (en) * 2013-09-12 2014-11-20 Bandwidth.Com, Inc. Predictive Caching of IP Data
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN105712923A (zh) * 2014-12-03 2016-06-29 江苏先声药业有限公司 一种尼达尼布杂质及其制备方法与应用
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
WO2017198202A1 (zh) * 2016-05-19 2017-11-23 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
WO2019048974A1 (en) * 2017-09-06 2019-03-14 Glenmark Pharmaceuticals Limited PROCESS FOR PREPARING NINTEDANIB
WO2019097112A1 (en) 2017-11-17 2019-05-23 Fermion Oy Synthesis of a 2-indolinone derivative known as intermediate for preparing nintedanib
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111377845A (zh) * 2018-12-27 2020-07-07 江苏先声药业有限公司 3-(二甲氨基(苯基)亚甲基)-2-氧化吲哚-6-羧酸甲酯及其制备方法与应用
CN111662223B (zh) * 2019-03-08 2023-07-14 四川科伦药物研究院有限公司 二氢吲哚酮衍生物及其中间体的制备方法
CA3191013A1 (en) * 2020-08-07 2022-02-10 Bdr Lifesciences Private Limited An improved highly efficient process for the prepration of nintedanib and pharmaceutically acceptable salt thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4876863A (ru) * 1972-01-22 1973-10-16
US6469181B1 (en) * 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
YU21301A (sh) * 1998-09-25 2003-04-30 Boehringer Ingelheim Pharama Gmbh. & Co. Kg. Novi supstituisani indolinoni sa inhibitorskim efektom za različite kinaze i komplekse ciklin/cdk
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
UA75054C2 (ru) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Замещенные в положении 6 индолиноны, их получение и их применение как лекарственного средства
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
WO2008056634A1 (fr) * 2006-11-06 2008-05-15 Theravalues Corporation Nouveau dérivé d'hydroxyindole
WO2009071523A1 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Process for the manufacture of an indolinone derivative
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion

Also Published As

Publication number Publication date
MA31989B1 (fr) 2011-01-03
EP2229360A2 (en) 2010-09-22
NZ585798A (en) 2011-06-30
HRP20201480T1 (hr) 2020-12-11
AR069531A1 (es) 2010-01-27
LT2229360T (lt) 2020-10-12
HUE051550T2 (hu) 2021-03-01
JP2011505346A (ja) 2011-02-24
CA2705490A1 (en) 2009-06-11
BRPI0819991A2 (pt) 2015-05-12
EA016196B1 (ru) 2012-03-30
SI2229360T1 (sl) 2020-11-30
AU2008333287B2 (en) 2013-12-19
IL205348A0 (en) 2010-12-30
ES2818993T3 (es) 2021-04-14
JP6044025B2 (ja) 2016-12-14
KR20150116909A (ko) 2015-10-16
MY148574A (en) 2013-04-30
PE20091445A1 (es) 2009-10-19
EP2229360B1 (en) 2020-07-01
UY31506A1 (es) 2009-08-03
KR101712810B1 (ko) 2017-03-07
CN101883755B (zh) 2013-06-26
HK1145682A1 (en) 2011-04-29
JP5933924B2 (ja) 2016-06-15
RS60818B1 (sr) 2020-10-30
BRPI0819991B1 (pt) 2022-02-15
TN2010000248A1 (fr) 2011-11-11
UA97872C2 (ru) 2012-03-26
CO6210751A2 (es) 2010-10-20
ZA201002723B (en) 2010-12-29
WO2009071524A2 (en) 2009-06-11
ECSP10010195A (es) 2010-07-30
DK2229360T3 (da) 2020-09-28
CN101883755A (zh) 2010-11-10
JP2015071602A (ja) 2015-04-16
KR101676261B1 (ko) 2016-11-15
AU2008333287A1 (en) 2009-06-11
PT2229360T (pt) 2020-09-15
PL2229360T3 (pl) 2020-12-14
IL205348A (en) 2014-06-30
US20100311985A1 (en) 2010-12-09
TWI432415B (zh) 2014-04-01
CL2008003599A1 (es) 2010-08-20
KR20100097129A (ko) 2010-09-02
CA2705490C (en) 2016-02-02
US8067617B2 (en) 2011-11-29
MX2010005557A (es) 2010-06-01
CY1123333T1 (el) 2021-12-31
TW200930702A (en) 2009-07-16
WO2009071524A3 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
EA201000883A1 (ru) Производные индолинона и способ их получения
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
TN2012000575A1 (en) Compositions and methods for modulating the wnt signaling pathway
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201100992A1 (ru) Карбазолкарбоксамидные соединения, применимые в качестве ингибиторов киназы
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201000269A1 (ru) Новые гербициды
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
EA201101148A1 (ru) Новые гербициды
EA200900945A1 (ru) Новый способ синтеза агомелатина
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201101146A1 (ru) Новые гербициды
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
EA201100920A1 (ru) Новые гербициды
EA200900946A1 (ru) Новый способ синтеза агомелатина
EA200870038A1 (ru) Способ получения аминов
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ